Delta-Fly PharmaTSE:4598 +2.27%30 Quick Ratio is 0.98 as of Mar. 2026, which is 91% below its 10-year median of 10.77. GuruFocus rates TSE:4598 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,409 Biotechnology companies, Delta-Fly Pharma ranks worse than 81.12% on this metric.
Delta-Fly Pharma has a quick ratio of 0.98. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Delta-Fly Pharma's Quick Ratio or its related term are showing as below:
TSE:4598'
s Quick Ratio Range Over the Past 10 Years
Min: 0.98 Med: 10.77 Max: 61.98
Current: 0.98
During the past 10 years, Delta-Fly Pharma's highest Quick Ratio was 61.98. The lowest was 0.98. And the median was 10.77.
TSE:4598's Quick Ratio is ranked worse than 81.12% of 1409
companies
in the Biotechnology industry
Industry Median: 3.6
vs TSE:4598: 0.98
Delta-Fly Pharma (TSE:4598) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Delta-Fly Pharma Quick Ratio Related Terms
Delta-Fly Pharma Quick Ratio Historical Data
* Premium members only.
The historical data trend for Delta-Fly Pharma's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4598 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Delta-Fly Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delta-Fly Pharma Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Delta-Fly Pharma's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Delta-Fly Pharma's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delta-Fly Pharma (TSE:4598) has a Quick Ratio of 0.98 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Delta-Fly Pharma and its competitors. This is 91% below median its historical median of 10.77. Over the past decade, Delta-Fly Pharma's Quick Ratio has ranged from 0.98 to 61.98. According to the industry distribution chart, Delta-Fly Pharma ranks #1143 out of 1409 companies in the Biotechnology industry, placing it in the top 81.1%.
Is Delta-Fly Pharma's Quick Ratio too high?
Delta-Fly Pharma's current Quick Ratio of 0.98 is 91% below median its 10-year median of 10.77. Over the past 10 years, this metric has ranged from a low of 0.98 to a high of 61.98. The Biotechnology industry median Quick Ratio is 3.60. Delta-Fly Pharma's value of 0.98 is 72.8% below this industry median. Based on the distribution chart, Delta-Fly Pharma ranks #1143 out of 1409 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Delta-Fly Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Delta-Fly Pharma ranks #1143 out of 1409 companies for Quick Ratio. This places Delta-Fly Pharma in the lower half of its industry. The industry median Quick Ratio is 3.60. Delta-Fly Pharma's value of 0.98 is 72.8% below this benchmark. Historically, Delta-Fly Pharma's own Quick Ratio has ranged from 0.98 to 61.98 over the past decade. While the company's 10-year median is 10.77 vs. the industry median of 3.60, Delta-Fly Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delta-Fly Pharma's current Quick Ratio of 0.98 is 72.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Delta-Fly Pharma and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delta-Fly Pharma's current Quick Ratio is 0.98, which is 91% below median its own 10-year median of 10.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Quick Ratio of 0.98. The current Quick Ratio is 0.98, which is 91% below median its 10-year median of 10.77 and 72.8% below the Biotechnology industry median of 3.60. Delta-Fly Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Quick Ratio is 0.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4598 has been successfully added to your 
